LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $11,535,858

Key CONT_AWD_75N91022F00016_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 367 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91022F00016_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91022F00016_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:03Z

Content hash 53cc7179ddb4555e15d7a3ac54e5fcbb0f744b8a729a5712eda944f2c52863b3

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$11,535,858	first version	September 9, 2022	September 3, 2025	2026-09-05T00:55:03Z	historical sweep	`53cc7179ddb4`

Archived copy

https://web.archive.org/web/20261012230250/https://www.usaspending.gov/award/CONT_AWD_75N91022F00016_7529_75N91019D00024_7529 captured by this system, October 12, 2026

What the amount is made of

5 recorded actions, so the amount is the award's current total across all of them. 4 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $13,973,744.

Action date	Modification	Type	Obligated	Description as recorded
September 23, 2026	P00004	OTHER ADMINISTRATIVE ACTION	+$2,437,886	NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES
September 3, 2025	P00003	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	−$220,697	EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
June 9, 2025	P00002	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	no money	EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
September 19, 2024	P00001	CHANGE ORDER	+$2,448,234	NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES
September 9, 2022	base	not on file	+$9,308,321	NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES

Last refreshed November 4, 2026 at 2:31 PM UTC.